General Surgery, Albury Wodonga Health, Albury Campus, 201 Borella Rd, Albury, NSW, 2640, USA.
Surg Endosc. 2022 Oct;36(10):7516-7520. doi: 10.1007/s00464-022-09184-z. Epub 2022 Mar 16.
Obesity is a growing global health burden which is particularly challenging to manage. Bariatric surgery is considered the most effective means of sustained weight loss, and Roux-en-Y gastric bypass is considered the most effective treatment for morbid obesity. The additional benefit of placing a non-adjustable band to form a banded Roux-en-Y gastric bypass has gained interest as a measure to improve weight loss; however, comparative data are few, and complications can be high.
We conducted a prospective case-control study of 484 patients aged 18 and over who received either banded Roux-en-Y gastric bypass with a non-adjustable silastic ring or Roux-en-Y gastric bypass. Patients were followed up for five years and evaluated for weight loss, percentage excess weight loss (%EWL), BMI, and band-related complications.
No significant difference was detected in %EWL or BMI between BRYGB and RYGB. The mean raw weight loss, %EWL, and BMI for BRYGB verse RYGB were as follows: 27.49 SD (17.11) kg verse 34.46 SD (18.18) kg, 65.7% SD (30%) verse 62.2% SD (37%), and 32.33 SD (6.9) kg/m verse 32.43 SD (7.2) kg/m. A total of 80 (21.7%) patients had the non-adjustable band removed for complications.
There is little difference in weight-loss results when comparing BRYGB to RYGB and non-adjustable bands may cause significant complications.
肥胖是一个日益严重的全球健康负担，尤其难以管理。减重手术被认为是持续减肥的最有效手段，而 Roux-en-Y 胃旁路手术被认为是治疗病态肥胖的最有效方法。放置不可调节带形成带 Roux-en-Y 胃旁路术作为改善减肥效果的一种措施引起了关注；然而，比较数据很少，并发症可能很高。
我们对 484 名年龄在 18 岁及以上的患者进行了前瞻性病例对照研究，这些患者接受了带不可调节硅酮环的带 Roux-en-Y 胃旁路手术或 Roux-en-Y 胃旁路手术。患者随访 5 年，评估体重减轻、多余体重百分比减轻（%EWL）、BMI 和带相关并发症。
BRYGB 和 RYGB 之间在 %EWL 或 BMI 方面没有显著差异。BRYGB 与 RYGB 的平均原始体重减轻、%EWL 和 BMI 如下：27.49 SD（17.11）kg 与 34.46 SD（18.18）kg，65.7% SD（30%）与 62.2% SD（37%），32.33 SD（6.9）kg/m 与 32.43 SD（7.2）kg/m。共有 80 名（21.7%）患者因并发症而移除不可调节带。
BRYGB 与 RYGB 相比，减肥效果差异不大，不可调节带可能会引起严重并发症。
